-
1دورية أكاديمية
المؤلفون: Chow, Laura Q. M., Barlesi, Fabrice, Bertino, Erin M., van den Bent, Martin J., Wakelee, Heather A., Wen, Patrick Y., Chiu, Chao-Hua, Orlov, Sergey, Chiari, Rita, Majem, Margarita, McKeage, Mark, Yu, Chong-Jen, Garrido, Pilar, Hurtado, Felipe K., Arratia, Pilar Cazorla, Song, Yuanbo, Branle, Fabrice, Shi, Michael, Kim, Dong-Wan
المساهمون: Kim, Dong-Wan
مصطلحات موضوعية: TYROSINE KINASE INHIBITORS, OPEN-LABEL, CRIZOTINIB, CHEMOTHERAPY, SURVIVAL, MANAGEMENT, DIAGNOSIS, CARCINOMATOSIS, ALECTINIB, OUTCOMES
العلاقة: Clinical Cancer Research, Vol.28 No.12, pp.2506-2516; https://hdl.handle.net/10371/184627Test; 000813269600001; 2-s2.0-85131604877; 165769
-
2دورية أكاديمية
المؤلفون: Hurtado, Felipe K., de Braud, Filippo, De Castro Carpeño, Javier, de Miguel Luken, Maria Jose, Wang, Ding, Scott, Jeffrey, Lau, Yvonne Y., McCulloch, Tracey, Mau-Sorensen, Morten
المصدر: Hurtado , F K , de Braud , F , De Castro Carpeño , J , de Miguel Luken , M J , Wang , D , Scott , J , Lau , Y Y , McCulloch , T & Mau-Sorensen , M 2021 , ' Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates : a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors ' , Cancer Chemotherapy and Pharmacology , vol. 87 , no. 4 , pp. 475-486 . https://doi.org/10.1007/s00280-020-04180-3Test
مصطلحات موضوعية: ALK inhibitor, Ceritinib, CYP2C9, CYP3A, Drug–drug interaction, Midazolam, Pharmacokinetics, Warfarin
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1007/s00280-020-04180-3Test
https://curis.ku.dk/portal/da/publications/effect-of-ceritinib-on-the-pharmacokinetics-of-coadministered-cyp3a-and-2c9-substratesTest(8b1ee85c-4824-47f5-a541-f7f001f03315).html
https://curis.ku.dk/ws/files/284296385/Hurtado2021_Article_EffectOfCeritinibOnThePharmaco.pdfTest -
3دورية أكاديمية
المؤلفون: Fischer, Matthias, Moreno, Lucas, Ziegler, David S., Marshall, Lynley V., Zwaan, C. Michel, Irwin, Meredith S., Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Geoerger, Birgit, Schulte, Johannes H.
المصدر: Fischer , M , Moreno , L , Ziegler , D S , Marshall , L V , Zwaan , C M , Irwin , M S , Casanova , M , Sabado , C , Wulff , B , Stegert , M , Wang , L , Hurtado , F K , Branle , F , Geoerger , B & Schulte , J H 2021 , ' Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies : an open-label, multicentre, phase 1, dose-escalation and dose-expansion study ' , The Lancet Oncology , vol. 22 , no. 12 , ....
الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00536-2
https://pure.eur.nl/en/publications/e356724a-0e45-47dc-a5b7-aae821e3805eTest
http://www.scopus.com/inward/record.url?scp=85119958039&partnerID=8YFLogxKTest -
4دورية أكاديمية
المؤلفون: Fischer, Matthias, Moreno, Lucas, Ziegler, David S., Marshall, Lynley, V, Zwaan, C. Michel, Irwin, Meredith S., Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Geoerger, Birgit, Schulte, Johannes H.
مصطلحات موضوعية: ddc:no
العلاقة: Fischer, Matthias, Moreno, Lucas, Ziegler, David S., Marshall, Lynley, V, Zwaan, C. Michel, Irwin, Meredith S., Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Geoerger, Birgit and Schulte, Johannes H. (2021). Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Lancet Oncol., 22 (12). S. 1764 - 1777. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
الإتاحة: https://kups.ub.uni-koeln.de/60505Test/
-
5دورية أكاديمية
المؤلفون: Hurtado, Felipe K, de Braud, Filippo, De Castro Carpeño, Javier, de Miguel Luken, Maria Jose, Wang, Ding, Scott, Jeffrey, Lau, Yvonne Y, McCulloch, Tracey, Mau-Sorensen, Morten
المصدر: Hematology/Oncology Articles
وصف الملف: application/pdf
العلاقة: https://scholarlycommons.henryford.com/hematologyoncology_articles/172Test; http://sfxhosted.exlibrisgroup.com/hfhs?sid=Entrez:PubMed&id=pmid:33394101Test
-
6دورية أكاديمية
المؤلفون: Hurtado, Felipe K., Weber, Benjamin, Derendorf, Hartmut, Hochhaus, Guenther, Dalla Costa, Teresa
المصدر: Antimicrobial Agents and Chemotherapy ; volume 58, issue 2, page 678-686 ; ISSN 0066-4804 1098-6596
-
7دورية أكاديمية
المؤلفون: Schulte, Johannes H., Moreno, Lucas, Ziegler, David Simon, Marshall, Lynley V., Zwaan, C. Michel, Irwin, Meredith, Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Fischer, Matthias, Geoerger, Birgit
مصطلحات موضوعية: ddc:no
العلاقة: Schulte, Johannes H., Moreno, Lucas, Ziegler, David Simon, Marshall, Lynley V., Zwaan, C. Michel, Irwin, Meredith, Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Fischer, Matthias and Geoerger, Birgit (2020). Final analysis of phase I study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
الإتاحة: https://kups.ub.uni-koeln.de/33327Test/
-
8دورية أكاديمية
المؤلفون: Heudi, Olivier, Plaud, Nathalie, Aumonier, Celine, Wu, Shari, Hatsis, Panos, Hurtado, Felipe K., Picard, Franck, Winter, Serge, Flarakos, Jimmy
المصدر: Biomedical Chromatography ; volume 34, issue 10 ; ISSN 0269-3879 1099-0801
الإتاحة: https://doi.org/10.1002/bmc.4909Test
-
9دورية أكاديمية
المصدر: Clinical Pharmacology & Therapeutics ; volume 104, issue 4, page 699-708 ; ISSN 0009-9236 1532-6535
الإتاحة: https://doi.org/10.1002/cpt.998Test
-
10دورية أكاديمية
المؤلفون: Hurtado, Felipe K., de Braud, Filippo, De Castro Carpeño, Javier, de Miguel Luken, Maria Jose, Wang, Ding, Scott, Jeffrey, Lau, Yvonne Y., McCulloch, Tracey, Mau-Sorensen, Morten
المصدر: Cancer Chemotherapy & Pharmacology; Apr2021, Vol. 87 Issue 4, p475-486, 12p
النص الكامل